Measures | Baseline | One year | ||
---|---|---|---|---|
 | C | I | C | I |
Objectively measured health behaviours | ||||
Physical activity (ActiHeart)[47] | Â | Â | X | X |
Dietary intake (plasma vitamin C concentration) | X | X | X | X |
Medication adherence (plasma drug concentrations) | Â | Â | X | X |
Smoking status (plasma cotinine concentration) | Â | Â | X | X |
Self-reported health behaviours | ||||
X | X | X | X | |
Dietary intake: EPIC food frequency questionnaire [54] | X | X | X | X |
Medication adherence: | Â | Â | Â | Â |
   All drugs during the last month [34] | X | X | X | X |
   Hypoglycaemic drugs during the last month [34] |  |  | X | X |
Smoking status and alcohol consumption (questionnaire) | X | X | X | X |
CVD risk | Â | Â | Â | Â |
Modelled ten-year CVD risk: UKPDS risk engine, v3 [33] | X | X | X | X |
Self-reported history of angina, heart attack and stroke | X | X | X | X |
Biochemical measures | ||||
HbA1c, total cholesterol, HDL and LDL cholesterol, triglyceride, urea and electrolytes, creatinine, albumin, bilirubin, alanine amino transferanse (ALT), alkaline phosphatase, aspartate aminotransference (AST), thyroid stimulating hormone (TSH), urine albumin/creatinine ratio | X | X | X | X |
Clinical measures | ||||
Waist circumference, height, weight, blood pressure, pulse, body fat impedance and ECG | X | X | X | X |
Cardiorespiratory fitness measured using a sub-maximal VO2 test[47] | Â | Â | X | X |
Rose angina questionnaire [55] | Â | Â | X | X |
Neuropathy questionnaire (adapted from the Michigan screening instrument) 1 | X | X | X | X |
Health utility, functional status, quality of life, well-being, treatment satisfaction and anxiety | ||||
Diabetes well-being (WBQ-28) [57] | Â | Â | X | X |
SF-36 [74] | Â | Â | X | X |
Diabetes-related quality of life (ADDQOL) [57] | Â | Â | X | X |
Diabetes Treatment satisfaction (DTS) [57] | Â | Â | X | X |
EuroQol EQ-5D [59] | X | X | X | X |
Consultation and relational empathy measure (CARE) [61] | Â | Â | X | X |
Spielberger Short form State anxiety inventory [60] | X | X | X | X |
Assessment of diabetes services | Â | Â | X | X |
Frequency of and views about self-monitoring of blood glucose (DiGEM questionnaire [62]) | Â | Â | X | X |
Beliefs about behaviour change, illness perceptions and habit | ||||
Beliefs about behaviour change: intention, perceived behavioural control, behavioural beliefs (physical activity, eating a low-fat diet; taking medication and smoking cessation) [29] | X | X | X | X |
Illness perceptions (consequences and treatment control sub-scales IPQ-R) [65] | X | X | X | X |
Diabetes knowledge1 | Â | Â | X | X |
Habit [67]) in relation to physical activity and dietary change | Â | Â | X | X |
Intervention evaluation | ||||
Facilitator assessment | Â | Â | Â | X |
Skills in last 12 months in relation to lifestyle change and medication taking1 | Â | Â | Â | X |
Costs | ||||
Self-reported current medication/vitamins | X | X | X | X |
Personal patient costs1 | X | X | Â | Â |
Health service and medication use in the previous three months (adapted from the Aberdeen Health Service Research Unit questionnaire) 1 | Â | Â | X | X |